Annual Conferences
You stay classy San Diego (April 2025)
AAN
Approved for medical use in the United States by the FDA in June 2021 in a controversial decision that led to the resignation of three advisers to the FDA.
Aducanumab/Aduhelm
Call it a Family Affair - I attended St. Johns University College of Pharmacy and Health Sciences with multiple members of my family
Andrew Piracha
Ouch - I studied p75NTR in pain for my Thesis
Shannon Buckley
I was the National Director of Neurology MSLs at what company
Lundbeck
The world's largest forum for the dementia research community
AAIC
It was granted accelerated approval for medical use in the United States in January 2023 and fully approved by the FDA in July 2023.
Lecanemab/Leqembi
Call it a tea Party - I completed my degree in this city, which is the birthplace of Dunkin Donuts
George Traykov
Shake Shake Shake - I studied the vulnerability of dopaminergic neurons in mouse models of Parkinson's disease using electrophysiology and imaging.
Javier Sanchez
I completed my postdoctoral training at this University in a city known for cheesesteaks
University of Pennsylvania/CHOP
The artistic and intellectual legacy of this 2025 conference location was was shaped by residents including Mozart, Beethoven and Sigmund Freud
AD/PD
In October 2024 this drug was approved for medical use in the United Kingdom by the Medicines and Healthcare products Regulatory Agency
Donanemab/Kinsula
Call me a cheese head - I did my graduate work at the University of Wisconsin–Madison
Yusuff Abdu
My head hurts - I studied Minocycline plus N‐acetylcysteine: A Novel therapeutic to treat traumatic brain injury
Michael Sangobowale
While completing my degree at this University I could sample the local cuisine of deep dish pizza's and Italian beef sandwiches
Northwestern University
Closely associated with the Journal of Prevention of Alzheimer’s Disease (JPAD), the conference’s official journal, publishes peer-reviewed articles, including reviews, original research, and short reports, on topics critical to Alzheimer’s prevention
CTAD
Developed by Roche this drug showed some amyloid plaque reduction but phase 3 trials did not demonstrate significant clinical benefit.
Gantenerumab
Call me CAM the Ram - My dissertation focused on the dense blood vessel network within the Paraventricular Nucleus of the Hypothalamus.
Krystle Frahm
Dr. Jekyll and Mr. Hyde - My work focused on postmortem human brain studies to examine psychiatric phenotypes
Ian Mahar
I hold a MBA from this Jesuit University - with a focus in health care management
Loyola University Chicago
Founded in 1969, _____________ now has nearly 35,000 members in more than 95 countries.
SFN
I was the first active immunotherapy strategy for Alzheimer's disease which consisted of a synthetic full-length Aβ peptide
AN-1792 Alzheimer's vaccine
Call it the Windy city - I completed my undergrad at DePaul University and graduate school at Northwestern University
Bryan McClarty
What happens in Vegas stays in Vegas - I held an adjunct professorship at the Department of Brain Health at UNLV
Garam Lee
In 2024 my favorite baseball team defeated the NY Yankees to win the World Series!!
Los Angeles Dodgers